See more : Ari Real Estate (Arena) Investment Ltd (ARIN.TA) Income Statement Analysis – Financial Results
Complete financial analysis of P3 Health Partners Inc. (PIII) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of P3 Health Partners Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- Wajax Corporation (WJX.TO) Income Statement Analysis – Financial Results
- Alltop Technology Co., Ltd. (3526.TWO) Income Statement Analysis – Financial Results
- Masco Corporation (0JZ1.L) Income Statement Analysis – Financial Results
- China Investment and Finance Group Limited (1226.HK) Income Statement Analysis – Financial Results
- Formosa Petrochemical Corporation (6505.TW) Income Statement Analysis – Financial Results
P3 Health Partners Inc. (PIII)
About P3 Health Partners Inc.
P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company is based in Henderson, Nevada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.27B | 1.05B | 491.06B | 485.54M | 145.48M | 87.70M |
| Cost of Revenue | 1.23B | 1.14B | 668.07M | 485.30M | 141.03M | 0.00 |
| Gross Profit | 31.64M | -95.01M | 490.40B | 243.70K | 4.45M | 87.70M |
| Gross Profit Ratio | 2.50% | -9.05% | 99.86% | 0.05% | 3.06% | 100.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 122.36M | 157.30M | 53.39B | 53.39M | 36.42M | 28.54M |
| Selling & Marketing | 3.23M | 5.10M | 1.50B | 1.50M | 801.69K | 1.87M |
| SG&A | 125.60M | 162.40M | 54.89B | 54.89M | 37.23M | 30.41M |
| Other Expenses | 73.97M | 1.13B | 464.76B | 465.77M | 147.79M | -103.73K |
| Operating Expenses | 199.57M | 1.30B | 519.65B | 520.66M | 185.02M | 137.41M |
| Cost & Expenses | 1.43B | 1.30B | 519.65B | 520.66M | 185.02M | 137.41M |
| Interest Income | 0.00 | 11.40M | 0.00 | 2.53M | 2.53M | 0.00 |
| Interest Expense | 15.99M | 11.40M | 10.68M | 2.53M | 2.53M | 0.00 |
| Depreciation & Amortization | 86.68M | 87.29M | 8.72M | 795.17K | 399.18K | 342.20K |
| EBITDA | -81.07M | -1.46B | -184.61M | -28.08M | -39.04M | -49.37M |
| EBITDA Ratio | -6.40% | -14.85% | -6.40% | -7.07% | -26.83% | -56.30% |
| Operating Income | -167.86M | -1.56B | -31.41B | -35.12M | -39.54M | -49.71M |
| Operating Income Ratio | -13.26% | -148.73% | -6.40% | -7.23% | -27.18% | -56.69% |
| Total Other Income/Expenses | -15.87M | 1.22M | -31.22B | -2.82M | -2.44M | -59.50K |
| Income Before Tax | -183.73M | -1.56B | -31.41B | -45.38M | -41.97M | -49.77M |
| Income Before Tax Ratio | -14.51% | -148.60% | -6.40% | -9.35% | -28.85% | -56.76% |
| Income Tax Expense | 2.70M | 1.90M | -31.40B | -4.00M | 2.63M | -6.02M |
| Net Income | -57.77M | -270.13M | -10.08M | -31.41M | -41.97M | -43.80M |
| Net Income Ratio | -4.56% | -25.74% | 0.00% | -6.47% | -28.85% | -49.95% |
| EPS | -0.61 | -6.50 | -0.24 | -0.79 | -0.88 | -0.64 |
| EPS Diluted | -0.20 | -6.50 | -0.24 | -0.79 | -0.88 | -0.64 |
| Weighted Avg Shares Out | 94.89M | 41.58M | 41.58M | 39.53M | 47.59M | 68.16M |
| Weighted Avg Shares Out (Dil) | 294.59M | 41.58M | 41.58M | 39.53M | 47.59M | 68.16M |
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Informs Shareholders of an Investigation into P3 Health Par
NEW YORK, NY / ACCESSWIRE / August 15, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own P3 Health Partners, Inc. ("PII" or the "Company") (NASDAQ:PIII) stock purchased prior to December...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation into P3 Health Pa
NEW YORK, NY / ACCESSWIRE / August 14, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own P3 Health Partners, Inc. ("PII" or the "Company") (NASDAQ:PIII) stock purchased prior to December...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Informs Shareholders of an Investigation into P3 Health Partners, Inc.
NEW YORK, NY / ACCESSWIRE / August 14, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own P3 Health Partners, Inc. ("PII" or the "Company") (NASDAQ:PIII) stock purchased prior to December...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into P3 Health Partn
NEW YORK, NY / ACCESSWIRE / August 12, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own P3 Health Partners, Inc. ("PII" or the "Company") (NASDAQ:PIII) stock purchased prior to December...
P3 Health Partners (PIII) Shows Fast-paced Momentum But Is Still a Bargain Stock
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, P3 Health Partners (PIII) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced...
P3 Health Partners Inc. (PIII) Q2 2024 Earnings Call Transcript
P3 Health Partners Inc. (NASDAQ:PIII ) Q2 2024 Earnings Call August 7, 2024 4:30 PM ET Company Participants Ryan Halsted - Investor Relations Aric Coffman - Chief Executive Officer Atul Kavthekar - Chief Financial Officer Amir Bacchus - Chief Medical...
P3 Health Partners Inc. (PIII) Reports Q2 Loss, Tops Revenue Estimates
P3 Health Partners Inc. (PIII) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to loss of $0.09 per share a year ago.
Will P3 Health Partners Inc. (PIII) Report Negative Earnings Next Week? What You Should Know
P3 Health Partners (PIII) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
P3 Health Partners: Moving In The Right Direction In 2024
P3 Health Partners is collaborating with healthcare providers in five states, providing assistance for compensation. The company's revenue has been steadily growing, but has not yet been profitable. However, profitability is expected in 2024. The recent announcement of a new...
P3 Health Partners to Present at Upcoming Investor Conferences
HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, will participate at the following upcoming investor conferences: The William Blair 44th Annual Growth Stock Conference in Chicago, IL on Tuesday, June 4,...
Source: https://incomestatements.info
Category: Stock Reports